Sobi had the pleasure of welcoming investors, analysts and other stakeholders to its Capital Markets Day on 18 February 2026. The event was hosted by Guido Oelkers, CEO, together with members of the management team.
The event provides an opportunity for stakeholders to gain insights into the company’s strategic direction ahead.
Agenda in short
- Guido Oelkers – CEO Sobi. Ambition 2030
- Lydia Abad-Franch – CMO Sobi. Pipeline and innovation at Sobi
- Robert Keenan – CMO Arthrosi. Disease Deep Dive: The painful burden of severe gout
- Duane Barnes, Sofiane Fahmy, Norbert Oppitz – Roundtable with Regional Heads
- Professor Klaus Parhofer – Disease Deep Dive: The silent risk of sHTG
- Professor Evangelos Giamarellos – Disease Deep dive: Precision medicine in sepsis
- Henrik Stenqvist – CFO Sobi. Delivering Shareholder Value
- Guido Oelkers – CEO Sobi. Wrap up and Q&A
Supporting documents
Presentation
Press release
Webcast timestamps
Opening - Gerard Tobin and Guido Oelkers
37.20.00 Lydia Abad-Franch – CMO Sobi
01.02.00 Robert Keenan – CMO Arthrosi
01.21.00 Duane Barnes, Sofiane Fahmy, Norbert Oppitz – Roundtable with Regional Heads
01.34.00 Professor Klaus Parhofer – Disease Deep Dive: The silent risk of sHTG
01.50.00 Professor Evangelos Giamarellos – Disease Deep dive: Precision medicine in sepsis
02.08.00 Henrik Stenqvist – CFO Sobi
02.20.00 Wrap up and Q&A